Logo image of MAMA

MAMA'S CREATIONS INC (MAMA) Stock Fundamental Analysis

NASDAQ:MAMA - Nasdaq - US56146T1034 - Common Stock - Currency: USD

7.94  -0.02 (-0.25%)

After market: 7.95 +0.01 (+0.13%)

Fundamental Rating

5

Taking everything into account, MAMA scores 5 out of 10 in our fundamental rating. MAMA was compared to 89 industry peers in the Food Products industry. Both the profitability and the financial health of MAMA get a neutral evaluation. Nothing too spectacular is happening here. MAMA shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year MAMA was profitable.
In the past year MAMA had a positive cash flow from operations.
MAMA had positive earnings in 4 of the past 5 years.
Each year in the past 5 years MAMA had a positive operating cash flow.
MAMA Yearly Net Income VS EBIT VS OCF VS FCFMAMA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M

1.2 Ratios

Looking at the Return On Assets, with a value of 7.89%, MAMA belongs to the top of the industry, outperforming 84.27% of the companies in the same industry.
With an excellent Return On Equity value of 14.91%, MAMA belongs to the best of the industry, outperforming 82.02% of the companies in the same industry.
MAMA has a Return On Invested Capital of 12.62%. This is amongst the best in the industry. MAMA outperforms 91.01% of its industry peers.
Industry RankSector Rank
ROA 7.89%
ROE 14.91%
ROIC 12.62%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MAMA Yearly ROA, ROE, ROICMAMA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400

1.3 Margins

MAMA's Profit Margin of 3.01% is in line compared to the rest of the industry. MAMA outperforms 57.30% of its industry peers.
MAMA's Profit Margin has declined in the last couple of years.
MAMA's Operating Margin of 3.95% is in line compared to the rest of the industry. MAMA outperforms 55.06% of its industry peers.
MAMA's Operating Margin has declined in the last couple of years.
MAMA has a Gross Margin (24.21%) which is in line with its industry peers.
MAMA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.95%
PM (TTM) 3.01%
GM 24.21%
OM growth 3Y185.5%
OM growth 5Y-8.49%
PM growth 3YN/A
PM growth 5Y-7.87%
GM growth 3Y0.31%
GM growth 5Y-3.01%
MAMA Yearly Profit, Operating, Gross MarginsMAMA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MAMA is still creating some value.
MAMA has more shares outstanding than it did 5 years ago.
MAMA Yearly Shares OutstandingMAMA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 10M 20M 30M
MAMA Yearly Total Debt VS Total AssetsMAMA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 10M 20M 30M 40M

2.2 Solvency

An Altman-Z score of 11.17 indicates that MAMA is not in any danger for bankruptcy at the moment.
The Altman-Z score of MAMA (11.17) is better than 96.63% of its industry peers.
MAMA has a debt to FCF ratio of 81.29. This is a negative value and a sign of low solvency as MAMA would need 81.29 years to pay back of all of its debts.
MAMA has a Debt to FCF ratio of 81.29. This is comparable to the rest of the industry: MAMA outperforms 50.56% of its industry peers.
MAMA has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
MAMA's Debt to Equity ratio of 0.10 is fine compared to the rest of the industry. MAMA outperforms 71.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 81.29
Altman-Z 11.17
ROIC/WACC1.38
WACC9.16%
MAMA Yearly LT Debt VS Equity VS FCFMAMA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M

2.3 Liquidity

MAMA has a Current Ratio of 1.28. This is a normal value and indicates that MAMA is financially healthy and should not expect problems in meeting its short term obligations.
MAMA has a Current ratio of 1.28. This is in the lower half of the industry: MAMA underperforms 64.04% of its industry peers.
A Quick Ratio of 1.00 indicates that MAMA should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.00, MAMA perfoms like the industry average, outperforming 56.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1
MAMA Yearly Current Assets VS Current LiabilitesMAMA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 5M 10M 15M 20M

7

3. Growth

3.1 Past

The earnings per share for MAMA have decreased strongly by -26.67% in the last year.
Measured over the past years, MAMA shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.61% on average per year.
Looking at the last year, MAMA shows a quite strong growth in Revenue. The Revenue has grown by 19.41% in the last year.
The Revenue has been growing by 29.59% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-26.67%
EPS 3YN/A
EPS 5Y17.61%
EPS Q2Q%200%
Revenue 1Y (TTM)19.41%
Revenue growth 3Y37.85%
Revenue growth 5Y29.59%
Sales Q2Q%18.15%

3.2 Future

Based on estimates for the next years, MAMA will show a very strong growth in Earnings Per Share. The EPS will grow by 73.30% on average per year.
The Revenue is expected to grow by 12.80% on average over the next years. This is quite good.
EPS Next Y98.33%
EPS Next 2Y73.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year14.72%
Revenue Next 2Y12.8%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MAMA Yearly Revenue VS EstimatesMAMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
MAMA Yearly EPS VS EstimatesMAMA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 0.2

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 72.18, the valuation of MAMA can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of MAMA is on the same level as its industry peers.
When comparing the Price/Earnings ratio of MAMA to the average of the S&P500 Index (26.55), we can say MAMA is valued expensively.
Based on the Price/Forward Earnings ratio of 29.37, the valuation of MAMA can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MAMA is on the same level as its industry peers.
MAMA's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.30.
Industry RankSector Rank
PE 72.18
Fwd PE 29.37
MAMA Price Earnings VS Forward Price EarningsMAMA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

64.04% of the companies in the same industry are cheaper than MAMA, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MAMA is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 3640.78
EV/EBITDA 37.2
MAMA Per share dataMAMA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

MAMA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MAMA's earnings are expected to grow with 73.30% in the coming years.
PEG (NY)0.73
PEG (5Y)4.1
EPS Next 2Y73.3%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for MAMA!.
Industry RankSector Rank
Dividend Yield N/A

MAMA'S CREATIONS INC

NASDAQ:MAMA (6/6/2025, 8:06:05 PM)

After market: 7.95 +0.01 (+0.13%)

7.94

-0.02 (-0.25%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)06-03 2025-06-03/amc
Earnings (Next)09-08 2025-09-08
Inst Owners69.86%
Inst Owner ChangeN/A
Ins Owners10.24%
Ins Owner Change2.77%
Market Cap298.54M
Analysts82
Price Target11.22 (41.31%)
Short Float %6.01%
Short Ratio7.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.63%
Min EPS beat(2)-73.86%
Max EPS beat(2)42.6%
EPS beat(4)2
Avg EPS beat(4)-17.51%
Min EPS beat(4)-73.86%
Max EPS beat(4)42.6%
EPS beat(8)6
Avg EPS beat(8)31.58%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.5%
Min Revenue beat(2)2.84%
Max Revenue beat(2)6.15%
Revenue beat(4)3
Avg Revenue beat(4)4.95%
Min Revenue beat(4)-1.14%
Max Revenue beat(4)11.95%
Revenue beat(8)7
Avg Revenue beat(8)4.25%
Revenue beat(12)10
Avg Revenue beat(12)4.05%
Revenue beat(16)13
Avg Revenue beat(16)3.03%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-8.33%
EPS NQ rev (3m)-15.38%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.57%
Revenue NY rev (1m)0.89%
Revenue NY rev (3m)1.52%
Valuation
Industry RankSector Rank
PE 72.18
Fwd PE 29.37
P/S 2.42
P/FCF 3640.78
P/OCF 57.67
P/B 11.99
P/tB 23.27
EV/EBITDA 37.2
EPS(TTM)0.11
EY1.39%
EPS(NY)0.27
Fwd EY3.4%
FCF(TTM)0
FCFY0.03%
OCF(TTM)0.14
OCFY1.73%
SpS3.28
BVpS0.66
TBVpS0.34
PEG (NY)0.73
PEG (5Y)4.1
Profitability
Industry RankSector Rank
ROA 7.89%
ROE 14.91%
ROCE 16.24%
ROIC 12.62%
ROICexc 16.56%
ROICexgc 35.03%
OM 3.95%
PM (TTM) 3.01%
GM 24.21%
FCFM 0.07%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y219.36%
ROICexcg growth 5Y-6.93%
ROICexc growth 3Y244.9%
ROICexc growth 5Y-16.03%
OM growth 3Y185.5%
OM growth 5Y-8.49%
PM growth 3YN/A
PM growth 5Y-7.87%
GM growth 3Y0.31%
GM growth 5Y-3.01%
F-ScoreN/A
Asset Turnover2.62
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 81.29
Debt/EBITDA 0.32
Cap/Depr 162.52%
Cap/Sales 4.13%
Interest Coverage 11.42
Cash Conversion 64.62%
Profit Quality 2.21%
Current Ratio 1.28
Quick Ratio 1
Altman-Z 11.17
F-ScoreN/A
WACC9.16%
ROIC/WACC1.38
Cap/Depr(3y)80.56%
Cap/Depr(5y)82.95%
Cap/Sales(3y)1.84%
Cap/Sales(5y)1.69%
Profit Quality(3y)128.45%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.67%
EPS 3YN/A
EPS 5Y17.61%
EPS Q2Q%200%
EPS Next Y98.33%
EPS Next 2Y73.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)19.41%
Revenue growth 3Y37.85%
Revenue growth 5Y29.59%
Sales Q2Q%18.15%
Revenue Next Year14.72%
Revenue Next 2Y12.8%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-45.15%
EBIT growth 3Y293.57%
EBIT growth 5Y18.58%
EBIT Next Year200.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-99.24%
FCF growth 3Y17.93%
FCF growth 5Y-44.38%
OCF growth 1Y-55.45%
OCF growth 3Y78.52%
OCF growth 5Y23.39%